Copyright Reports & Markets. All rights reserved.

Global Sarcopenia Treatments Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Sarcopenia Treatments by Type
    • 1.3.1 Overview: Global Sarcopenia Treatments Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Sarcopenia Treatments Consumption Value Market Share by Type in 2023
    • 1.3.3 Protein Supplement
    • 1.3.4 Calcium Supplement
    • 1.3.5 Other
  • 1.4 Global Sarcopenia Treatments Market by Application
    • 1.4.1 Overview: Global Sarcopenia Treatments Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Online Pharmacies
    • 1.4.3 Retail Pharmacies
  • 1.5 Global Sarcopenia Treatments Market Size & Forecast
  • 1.6 Global Sarcopenia Treatments Market Size and Forecast by Region
    • 1.6.1 Global Sarcopenia Treatments Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Sarcopenia Treatments Market Size by Region, (2019-2030)
    • 1.6.3 North America Sarcopenia Treatments Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Sarcopenia Treatments Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Sarcopenia Treatments Market Size and Prospect (2019-2030)
    • 1.6.6 South America Sarcopenia Treatments Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Sarcopenia Treatments Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Abbott Laboratories
    • 2.1.1 Abbott Laboratories Details
    • 2.1.2 Abbott Laboratories Major Business
    • 2.1.3 Abbott Laboratories Sarcopenia Treatments Product and Solutions
    • 2.1.4 Abbott Laboratories Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.2 Nestlé
    • 2.2.1 Nestlé Details
    • 2.2.2 Nestlé Major Business
    • 2.2.3 Nestlé Sarcopenia Treatments Product and Solutions
    • 2.2.4 Nestlé Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Nestlé Recent Developments and Future Plans
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer Sarcopenia Treatments Product and Solutions
    • 2.3.4 Pfizer Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Pfizer Recent Developments and Future Plans
  • 2.4 Amway
    • 2.4.1 Amway Details
    • 2.4.2 Amway Major Business
    • 2.4.3 Amway Sarcopenia Treatments Product and Solutions
    • 2.4.4 Amway Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Amway Recent Developments and Future Plans
  • 2.5 By-health
    • 2.5.1 By-health Details
    • 2.5.2 By-health Major Business
    • 2.5.3 By-health Sarcopenia Treatments Product and Solutions
    • 2.5.4 By-health Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 By-health Recent Developments and Future Plans
  • 2.6 Usana
    • 2.6.1 Usana Details
    • 2.6.2 Usana Major Business
    • 2.6.3 Usana Sarcopenia Treatments Product and Solutions
    • 2.6.4 Usana Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Usana Recent Developments and Future Plans
  • 2.7 A&Z Pharmaceutical
    • 2.7.1 A&Z Pharmaceutical Details
    • 2.7.2 A&Z Pharmaceutical Major Business
    • 2.7.3 A&Z Pharmaceutical Sarcopenia Treatments Product and Solutions
    • 2.7.4 A&Z Pharmaceutical Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 A&Z Pharmaceutical Recent Developments and Future Plans
  • 2.8 GlaxoSmithKline
    • 2.8.1 GlaxoSmithKline Details
    • 2.8.2 GlaxoSmithKline Major Business
    • 2.8.3 GlaxoSmithKline Sarcopenia Treatments Product and Solutions
    • 2.8.4 GlaxoSmithKline Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.9 Bayer
    • 2.9.1 Bayer Details
    • 2.9.2 Bayer Major Business
    • 2.9.3 Bayer Sarcopenia Treatments Product and Solutions
    • 2.9.4 Bayer Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Bayer Recent Developments and Future Plans
  • 2.10 H&H
    • 2.10.1 H&H Details
    • 2.10.2 H&H Major Business
    • 2.10.3 H&H Sarcopenia Treatments Product and Solutions
    • 2.10.4 H&H Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 H&H Recent Developments and Future Plans
  • 2.11 Blackmores
    • 2.11.1 Blackmores Details
    • 2.11.2 Blackmores Major Business
    • 2.11.3 Blackmores Sarcopenia Treatments Product and Solutions
    • 2.11.4 Blackmores Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Blackmores Recent Developments and Future Plans
  • 2.12 Zhendong Group
    • 2.12.1 Zhendong Group Details
    • 2.12.2 Zhendong Group Major Business
    • 2.12.3 Zhendong Group Sarcopenia Treatments Product and Solutions
    • 2.12.4 Zhendong Group Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Zhendong Group Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Sarcopenia Treatments Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Sarcopenia Treatments by Company Revenue
    • 3.2.2 Top 3 Sarcopenia Treatments Players Market Share in 2023
    • 3.2.3 Top 6 Sarcopenia Treatments Players Market Share in 2023
  • 3.3 Sarcopenia Treatments Market: Overall Company Footprint Analysis
    • 3.3.1 Sarcopenia Treatments Market: Region Footprint
    • 3.3.2 Sarcopenia Treatments Market: Company Product Type Footprint
    • 3.3.3 Sarcopenia Treatments Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Sarcopenia Treatments Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Sarcopenia Treatments Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Sarcopenia Treatments Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Sarcopenia Treatments Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Sarcopenia Treatments Consumption Value by Type (2019-2030)
  • 6.2 North America Sarcopenia Treatments Market Size by Application (2019-2030)
  • 6.3 North America Sarcopenia Treatments Market Size by Country
    • 6.3.1 North America Sarcopenia Treatments Consumption Value by Country (2019-2030)
    • 6.3.2 United States Sarcopenia Treatments Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Sarcopenia Treatments Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Sarcopenia Treatments Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Sarcopenia Treatments Consumption Value by Type (2019-2030)
  • 7.2 Europe Sarcopenia Treatments Consumption Value by Application (2019-2030)
  • 7.3 Europe Sarcopenia Treatments Market Size by Country
    • 7.3.1 Europe Sarcopenia Treatments Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Sarcopenia Treatments Market Size and Forecast (2019-2030)
    • 7.3.3 France Sarcopenia Treatments Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Sarcopenia Treatments Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Sarcopenia Treatments Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Sarcopenia Treatments Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Sarcopenia Treatments Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Sarcopenia Treatments Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Sarcopenia Treatments Market Size by Region
    • 8.3.1 Asia-Pacific Sarcopenia Treatments Consumption Value by Region (2019-2030)
    • 8.3.2 China Sarcopenia Treatments Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Sarcopenia Treatments Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Sarcopenia Treatments Market Size and Forecast (2019-2030)
    • 8.3.5 India Sarcopenia Treatments Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Sarcopenia Treatments Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Sarcopenia Treatments Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Sarcopenia Treatments Consumption Value by Type (2019-2030)
  • 9.2 South America Sarcopenia Treatments Consumption Value by Application (2019-2030)
  • 9.3 South America Sarcopenia Treatments Market Size by Country
    • 9.3.1 South America Sarcopenia Treatments Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Sarcopenia Treatments Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Sarcopenia Treatments Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Sarcopenia Treatments Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Sarcopenia Treatments Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Sarcopenia Treatments Market Size by Country
    • 10.3.1 Middle East & Africa Sarcopenia Treatments Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Sarcopenia Treatments Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Sarcopenia Treatments Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Sarcopenia Treatments Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Sarcopenia Treatments Market Drivers
  • 11.2 Sarcopenia Treatments Market Restraints
  • 11.3 Sarcopenia Treatments Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Sarcopenia Treatments Industry Chain
  • 12.2 Sarcopenia Treatments Upstream Analysis
  • 12.3 Sarcopenia Treatments Midstream Analysis
  • 12.4 Sarcopenia Treatments Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.
    According to our (Global Info Research) latest study, the global Sarcopenia Treatments market size was valued at US$ 2985 million in 2023 and is forecast to a readjusted size of USD 4046 million by 2030 with a CAGR of 4.5% during review period.
    China is the largest consumption region of Sarcopenia Treatment, with market share nearly 30.83%. The second largest market is United States; following China with the market share of 24.48%.
    This report is a detailed and comprehensive analysis for global Sarcopenia Treatments market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Sarcopenia Treatments market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Sarcopenia Treatments market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Sarcopenia Treatments market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Sarcopenia Treatments market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Sarcopenia Treatments
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Sarcopenia Treatments market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Nestlé, Pfizer, Amway, By-health, Usana, A&Z Pharmaceutical, GlaxoSmithKline, Bayer, H&H, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Sarcopenia Treatments market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Sarcopenia Treatments market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Protein Supplement
    Calcium Supplement
    Other
    Market segment by Application
    Online Pharmacies
    Retail Pharmacies
    Market segment by players, this report covers
    Abbott Laboratories
    Nestlé
    Pfizer
    Amway
    By-health
    Usana
    A&Z Pharmaceutical
    GlaxoSmithKline
    Bayer
    H&H
    Blackmores
    Zhendong Group
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Sarcopenia Treatments product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Sarcopenia Treatments, with revenue, gross margin, and global market share of Sarcopenia Treatments from 2019 to 2024.
    Chapter 3, the Sarcopenia Treatments competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Sarcopenia Treatments market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Sarcopenia Treatments.
    Chapter 13, to describe Sarcopenia Treatments research findings and conclusion.

    Buy now